Foundation Medicine, Inc. is a precision medicine company that develops genomic profiling assays based on next-generation sequencing for oncology applications. Headquartered in Boston, Massachusetts, with additional laboratories in North Carolina and Germany, the company provides comprehensive genomic profiling tests to identify molecular alterations in solid tumors, hematologic malignancies, and other cancers. Founded in 2010, it has operated as a wholly owned subsidiary of Roche since completing its acquisition in 2018. Foundation Medicine focuses on companion diagnostics and supports treatment selection, clinical trial matching, and biopharmaceutical research in cancer care.
Official website: foundationmedicine.com
To provide comprehensive coverage, we aggregate data and news under the name Foundation Medicine, encompassing the following company names, divisions, and related entities:
FMI.
This list encompasses current and former names, alternate names, and key divisions associated with Foundation Medicine, ensuring you can easily find all relevant information under a single, unified profile.
